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The purpose of this study is to investigate feasibility of sodium lauryl sulfoacetate (SLS) as an immunoadjuvant in chickens. After
treating with 62.5, 125, 250, or 500μg/mL SLS in vitro, lymphocyte proliferation assay of chicken peripheral blood mononuclear
cellsshowedthattheOD570 valuesofallexperimentalgroups,aswellasConA-stimulatedgroup,weresigniﬁcantlyhigherthanthat
of the untreated control group. After injection with 1.0, 2.0, or 4.0mg/kg of SLS for 3 consecutive days, chickens were vaccinated




speciﬁc antibody response and increase CD4
+/CD8
+ T-cell ratio in vivo. Furthermore, SLS could improve NDV-speciﬁc antibody
response in thiamphenicol-treated chickens. These data indicate that SLS not only can improve humoral immune response but
also reverse the immunosuppressive eﬀect of thiamphenicol in chickens.
1.Introduction
Houttuynia cordata thunb(Saururaceae,HC)isatherapeutic
drug which has been used for the treatment of infections,
allergy and cancers [1–9]. The major active component of
the herb is houttuynin, which is present in the fraction
of volatile oil with antimicrobial, antioxidative, antimuta-
genic, and immunoadjuvant eﬀects [10–12]. The modiﬁed
form of houttuynin, called sodium houttuyfonate (SH,
C12H23NaO5S, MW 302.36), has potent immunoadjuvant
eﬀects including promotion of phagocytosis and secretion
of lysozyme, acidic phosphatase and IL-1β by macrophages
[13–16]. To reduce the cytotoxicitic eﬀect of SH, sodium
laurylsulfoacetate(SLS,brandnameissodiumnewhouttuy-
f o n a t e ,S N H ,C 14H27NaO5S, MW 330.4, Figure 1)h a sb e e n
generated by additive reaction with houttuynin and sodium
bisulﬁte, which has also been widely used for the treat-
ment of infections, inﬂammation, anaphylaxis, and cancers
[17, 18].
To investigate the feasibility of SLS as an immunoad-
juvant for chickens, in this study lymphocyte prolifera-
tion assay was performed using chicken peripheral blood
mononuclear cells (PBMCs) in the presence of diﬀerent
doses of SLS. Then, the in vivo immunoadjuvant eﬀect was
conﬁrmed according to the immune organ index, antibody
response, and CD4
+/CD8
+ T-cell ratio of the chickens
vaccinated with an attenuated vaccine against Newcastle
disease virus (NDV) with SLS or SLS plus thiamphenicol
treatment.
2.MaterialsandMethods
2.1. Materials and Animals. 11-day-old unvaccinated local
breed Shanhuang chickens were provided by the Jiangsu
Institute of Poultry Science. 0.2% SLS in 0.85% sodium
chloride solution was provided by the Animal Pharma-
ceutical Center, Jiangsu Animal Husbandry and Veteri-
nary College. Ficoll-paque lymphocyte separation medium
(5.7% (w/v) ﬁcoll 400, 9.0% (w/v) sodium diatrizoate,
and D = 1.077 ± 0.002) was from Shanghai Huajing
Bio-tech Company Limited. RPMI 1640 medium was the
product of GIBCO (USA). Fetal calf serum (FCS) was
purchased from Hangzhou Sijiqing Biological Engineer-
ing Materials Company Limited. Concanavalin A (Con




Figure 1: Chemical structure of sodium lauryl sulfoacetate.
dimethyl sulfoxide (DMSO) were purchased from Sigma.
LaSota NDV vaccine was obtained from QianYuanHao Bio-
logical Company Limited. Florfenicol pellets (0.25g/piece)
were purchased from Shanghai Animal Drug Factory. Flu-
orescein isothiocyanate- (FITC-) labeled monoclonal anti-
body against chicken CD4, phycoerythrin- (PE-) labeled
monoclonal antibody against chicken CD8a, and biotin-
labeled monoclonal antibody against chicken CD3 were
purchased from Southern Biotech (USA). Streptavidin-
allophycocyanin was purchased from Becton Dickinson
(USA).
2.2. Lymphocyte Proliferation Assay. 10mL of pooled blood
sample was collected from 10 chickens and onefold was
diluted with PBS. PBMCs were separated by density gradient
centrifugationon14mLFicoll-paquelymphocyteseparation
medium at 400g for 15 minutes and resuspended (1×106
cells/mL) in RPMI 1640 medium supplemented with 10%
FCS, 100IU/mL penicillin, and 100μg/mL streptomycin
[19]. Lymphocyte proliferation was measured using MTT
method as described [20]. Brieﬂy, 100μL of the cell sus-
pension was dispersed into each well of 96-well plates and
then 62.5, 125, 250 or 500μg/mL SLS was added (n = 12).
After incubation at 39.5
◦C, 5% CO2 for 44 hours, 10μL
MTT(5mg/mL)wasaddedintoeachwellandtheincubation
was continued for 4 hours. Then 100μLo fD M S Ow a s
added and incubation was continued for additional 24 hours
before measurement for OD570 values using an ELISA reader
(Bio-Tek Instruments, VT). The cell suspension without SLS
treatment and with 5μg/mL Con A was used as the negative
and positive control, respectively.
2.3. Immunization and Antibody Detection. One hundred
forty-four chickens were randomly divided into 4 groups.
Thethreeexperimentalgroupswereintramuscularlyinjected
with 1, 2, or 4mg/kg of SLS for 3 consecutive days and
the control group was treated in the same way with normal
saline. On the third day after injection, all birds were
intranasally vaccinated with LaSota NDV vaccine and the
immunization was boosted on day 17. On day 10, 17, 24, 31,
38, or 45 after SLS primary treatment, serum samples were
collected from all birds and the NDV-speciﬁc antibody was
titrated using standard hemagglutination inhibition (HI)
assay [19].
2.4. Determination of CD4
+/CD8
+ T-cell Ratio and Immune
Organ Indices. On day 10, 17, 24, 31, 38, or 45 after SLS
treatment, 6 chickens of each group were sacriﬁced and the
blood samples were collected for lymphocyte separation.
CD4
+/CD8
+ T-cell ratio in PBMCs was measured using
Table 1: Promotion of chicken PBMC proliferation by SLS.
Group (dose) OD570
SLS (500μg/mL) 0.154 ±0.015∗
SLS (250μg/mL) 0.171 ±0.024∗
SLS (125μg/mL) 0.158 ±0.017∗
SLS (62.5μg/mL) 0.140 ±0.031∗
Con A (5μg/mL) 0.149 ±0.017∗
Normal saline 0.073 ±0.012
The data are expressed as mean ± SD (n = 12) in relation to the blank well.
∗P <. 05 was accepted as signiﬁcant diﬀerences compared to the normal
saline control.
ﬂow cytometry [21]. Brieﬂy, 2×106 cells from each chicken
were incubated at 4◦C for 45 minutes with an FITC-labeled
monoclonal antibody against chicken CD4, a PE-labeled
monoclonal antibody against chicken CD8, and a biotin-
labeled monoclonal antibody against chicken CD3.A f t e r
two washings with PBS, the cells were incubated at 4◦C
for 30 minutes with streptavidin-allophycocyanin conjugate.
After two additional washings, CD4
+/CD8
+ T-cell ratio was
determined by ﬂow cytometry. At the end of the experiment,
the spleen, thymus, and bursa of Fabricius of each chicken
were collected for organ index calculation [22].
2.5. Determination of Anti-Immunosuppressive Eﬀect of SLS in
Chickens. One hundred and eight chickens were separated
into three groups. Each bird in experimental group I was
intramuscularly injected with 2.0mg/kg SLS and then orally
administered with 1.2g/kg thiamphenicol for 3 consecutive
days, while the birds in experimental group II or control
group were treated in the same way with 1.2g/kg thi-
amphenicol or normal saline only. On the third day after
treatment,allbirdswereintranasallyimmunizedwithLaSota
NDV vaccine and boosted on day 17. On day 10, 17, 24,
31, 38, or 45 after SLS treatment, the serum samples and
PBMCs were prepared for determining the NDV-speciﬁc
antibody response and CD4
+/CD8
+ T-cell ratio as previously
described.
2.6. Statistical Analysis. The signiﬁcant diﬀerence of the
averaged data was analyzed using t-test (P<. 05).
3. Results
3.1. Enhancement of Lymphocyte Proliferation by SLS. After
treatment for 44 hours with 62.5, 125, 250, or 500μg/mL
SLS, the OD570 values of all experimental groups were
signiﬁcantly higher than those of the control group, which
wascomparabletothatofConA-stimulatedgroup(Table 1).
Among the four concentrations of SLS tested, the 250 μg
group had the highest stimulatory eﬀect on chicken PBMCs,
but the diﬀerence was not signiﬁcant.
3.2. Enhancement of Immune Response by SLS. After treat-
ment with diﬀerent doses of SLS or normal saline, all
chickens were vaccinated twice with live NDV vaccine, andVeterinary Medicine International 3
Table 2: The antibody response in SLS-treated and vaccinated chickens.
Group (dose) HI titer on diﬀerent days after primary immunization (log2)
10d 17d 24d 31d 38d 45d
SLS (4mg/kg) 5.31 ±0.25 6.02 ±0.45 6.87 ±0.27 7.68 ±0.33∗ 7.06 ±0.41 6.53 ±0.28
SLS (2mg/kg) 5.72 ±0.19 6.83 ±0.33∗ 7.46 ±0.49∗ 8.79 ±0.11∗ 8.87 ±0.52∗ 8.15 ±0.19∗
SLS (1mg/kg) 5.11 ±0.32 6.21 ±0.42 6.75 ±0.32 8.02 ±0.29∗ 7.46 ±0.54 6.92 ±0.16
Normal saline 4.71 ±0.37 5.12 ±0.39 5.51 ±0.37 6.03 ±0.24 6.14 ±0.21 5.83 ±0.31
The data are expressed as mean ± SD (day 10, n = 36; day 17, n = 30; day 24, n = 24; day 31, n = 18; day 38, n = 12; day 45, n = 6) in relation to the HI
titers of chickens. ∗P <. 05 was accepted as signiﬁcant diﬀerences compared to the normal saline control group.
Table 3: The CD4
+/CD8
+ T-cell ratio in PBMCs of SLS-treated and vaccinated chickens.
Group (dose) CD4
+/CD8
+ T-cell ratio on diﬀerent days after primary immunization
10d 17d 24d 31d 38d 45d
SLS (4mg/kg) 2.15 ±0.22 2.31 ±0.25 2.48 ±0.22 3.29 ±0.27∗ 2.94 ±0.21∗ 2.46 ±0.21
SLS (2mg/kg) 2.21 ±0.28 2.49 ±0.23 2.80 ±0.17∗ 3.57 ±0.31∗ 3.50 ±0.19∗ 3.21 ±0.24∗
SLS (1mg/kg) 2.13 ±0.16 2.24 ±0.22 2.45 ±0.25 3.41 ±0.19∗ 3.10 ±0.14∗ 2.47 ±0.22
Normal saline 2.10 ±0.23 2.16 ±0.29 2.19 ±0.11 2.30 ±0.23 2.25 ±0.25 2.11 ±0.32
The data are expressed as mean ± SD (n = 6) in relation to the CD4
+/CD8
+ T-cell ratio of chickens. ∗P <. 05 was accepted as signiﬁcant diﬀerences
compared to the normal saline control group.
Table 4: Inﬂuence of SLS on immune organ indices of NDV-vaccinated chickens.
Organs Group (dose) Organ index
10d 17d 24d 31d 38d 45d
Thymus
SLS (4mg/kg) 0.335 ±0.015 0.351 ±0.026 0.384 ±0.021 0.366 ±0.022 0.360 ±0.024 0.335 ±0.015
SLS (2mg/kg) 0.327 ±0.027 0.352 ±0.023 0.383 ±0.029 0.368 ±0.019 0.361 ±0.021 0.327 ±0.027
SLS (1mg/kg) 0.333 ±0.028 0.359 ±0.016 0.380 ±0.028 0.365 ±0.031 0.363 ±0.026 0.333 ±0.028
Normal saline 0.328 ±0.025 0.357 ±0.025 0.380 ±0.014 0.364 ±0.023 0.362 ±0.024 0.328 ±0.025
Spleen
SLS (4mg/kg) 0.163 ±0.018 0.222 ±0.025 0.265 ±0.023 0.270 ±0.027 0.242 ±0.020 0.232 ±0.017
SLS (2mg/kg) 0.169 ±0.019 0.226 ±0.021 0.270 ±0.012 0.276 ±0.018 0.246 ±0.017 0.269 ±0.016
SLS (1mg/kg) 0.160 ±0.029 0.223 ±0.026 0.264 ±0.019 0.273 ±0.022 0.243 ±0.016 0.230 ±0.019
Normal saline 0.163 ±0.016 0.224 ±0.013 0.266 ±0.011 0.274 ±0.027 0.244 ±0.015 0.234 ±0.014
Cloacal bursa
SLS (4mg/kg) 0.331 ±0.031 0.354 ±0.027 0.373 ±0.025 0.355 ±0.022 0.349 ±0.021 0.321 ±0.022
SLS (2mg/kg) 0.329 ±0.030 0.357 ±0.029 0.369 ±0.033 0.368 ±0.028 0.359 ±0.025 0.325 ±0.023
SLS (1mg/kg) 0.330 ±0.026 0.355 ±0.031 0.371 ±0.037 0.363 ±0.032 0.357 ±0.029 0.328 ±0.024
Normal saline 0.332 ±0.019 0.352 ±0.022 0.370 ±0.027 0.355 ±0.028 0.348 ±0.024 0.331 ±0.017
The data are expressed as mean ± SD (n = 6).
Table 5: Anti-immunosuppressive eﬀect of SLS on thiamphenicol.
Group HI titer on diﬀerent days after immunization (log2)
10d 17d 24d 31d 38d 45d
SLS+Florfenicol 4.82 ±0.29 5.09 ±0.19 5.46 ±0.24 6.26 ±0.19 6.76 ±0.24 6.43 ±0.19
Florfenicol 3.01 ±0.21∗ 3.43 ±0.13∗ 3.83 ±0.28∗ 4.06 ±0.33∗ 3.96 ±0.28∗ 3.83 ±0.33∗
Saline 4.52 ±0.35 5.05 ±0.36 5.61 ±0.34 6.07 ±0.24 6.21 ±0.21 5.82 ±0.31
The data are expressed as mean ± SD (day 10, n = 36; day 17, n = 30; day 24, n = 24; day 31, n = 18; day 38, n = 12; day 45, n = 6) in relation to the HI
titers of chickens. ∗P <. 05 was accepted as signiﬁcant diﬀerences compared to the saline control group.
Table 6: Inﬂuence of SLS on CD4
+/CD8




10d 17d 24d 31d 38d 45d
SLS+Florfenicol 2.15 ±0.23 2.24 ±0.19 2.61 ±0.17 3.01 ± 0.18∗ 2.98 ±0.24∗ 2.74 ±0.21∗
Florfenicol 2.01 ±0.19 2.02 ±0.24 2.02 ±0.27 2.04 ±0.23 2.03 ±0.27 2.00 ±0.22
Saline 2.09 ±0.22 2.18 ±0.27 2.19 ±0.15 2.30 ±0.23 2.23 ±0.24 2.11 ±0.31
The data are expressed as mean ± SD (n = 6) in relation to the CD4
+/CD8
+ T-cell ratio of chickens. ∗P <. 05 was accepted as signiﬁcant diﬀerences
compared to the saline control group.4 Veterinary Medicine International
serum samples were collected on diﬀerent days after primary
immunization for NDV-speciﬁc antibody assay. As Table 2
shows, HI titers of the three experimental groups were 1 or
2 log2 higher than that of the normal saline control group.
Among the three doses tested, the 2mg group had HI titers
about 1 log2 higher than those of the other two groups from
day 17 after SLS treatment.
To further investigate the enhancive eﬀect of SLS on anti-
body response in vaccinated chickens, blood samples were
collected on diﬀerent days after vaccination and CD4
+/CD8
+
T-cell ratios in PBMCs were measured by ﬂow cytometry.
As Table 3 shows, all the three experimental groups had
signiﬁcant higher (P<. 05) CD4
+/CD8
+ T-cell ratios than
that of the saline control group from day 31 after SLS
treatment. Similar to the antibody response, the 2-mg group
has slightly higher CD4
+/CD8
+ T-cell ratio than that of the
other two experimental groups.
3.3. Inﬂuence of SLS on Chicken Immune Organs. On dif-
ferent days after SLS treatment and NDV vaccination, the
thymus, spleen, and bursa of Fabricius of each chicken
were collected and weighted for organ index calculation. As
Table 4 shows,theindicesofthethreerepresentativeimmune
organs of the three SLS dose groups had no signiﬁcant
diﬀerences compared to that of the saline control group.
3.4. Anti-Immunosuppressive Eﬀect of SLS in Chickens. After
treatment with SLS plus thiamphenicol, thiamphenicol, or
normal saline for successive 3 days, all birds were immunized
with LaSota NDV vaccine and their serum samples and
PBMCs were collected for NDV-speciﬁc antibody titration
and CD4
+/CD8
+ T-cell ratio determination. As Table 5
shows, HI titer of the SLS plus thiamphenicol-treated group
was signiﬁcantly higher than that of the thiamphenicol-
treated group from day 10 after SLS treatment, which was




group had higher score than that of thiamphenicol-treated
group from day 10, but signiﬁcant diﬀerences were found
only from day 31 after SLS treatment (Table 6).
4. Discussions
Traditional Chinese medicine (TCM) has been widely used
for thousands of years, and Chinese scientists have unveiled
that many recipes of TCM have played a role in helping to
improve the immune system of humans and animals [13].
But it is also facing many challenges; especially, the active
ingredients of the most herbs and the role of the active
components are still unclear or indistinct. SLS is synthesized
artiﬁcially by using sodium bisulﬁte and houttuynin and has
been used in the clinic for many years. Recent research has
revealed the adjuvant activity and the possible mechanism of
SH [13–16]. Whether SLS, the analogue of SH, has a similar
eﬀect still needed to be demonstrated.
To this end, in this study the immunoadjuvant eﬀects of
SLSwereinvestigatedinvitroandinvivo.Theresultsshowed
that SLS with suitable dose could not only promote the
proliferation of chicken PBMCs in vitro but also enhance the
NDV-speciﬁc antibody response in chickens. The possible
reason(s) for this could be due to the increase in chicken
CD4
+/CD8
+ T-cell ratio, which indicates the shift of cellular
immune response to humoral response [23], since no
signiﬁcant diﬀerences in lymphoid organ development were
foundafterSLStreatment.Whetherthiseﬀectoccursalsofor
other vaccines needs further research.
Thiamphenicol is a popular antibiotic, which is widely
used for treatment of bacterial diseases in animals. However,
like many other antibiotics, the antibiotic has overt side
eﬀects including immunosuppression [24]. Interestingly,
the data of this study showed that SLS could promote
NDV-speciﬁc antibody response in thiamphenicol-treated
chickens. Although the detailed mechanism(s) remains to
be deﬁned, the experimental data warrant us to further
investigatethefeasibilityofSLStoreversehumoralimmuno-
suppression in other antibiotic(s)-used chickens. This may
further widen our knowledge about the role and utilization
of TCM in the future.
Acknowledgments
This work was supported by Natural Science Foundation
of Jiangsu Province, China (Grant no. BK2006085). The
authors would like to give our thanks to all the staﬀ of the
Testing Centre of Yangzhou University for their help with
some experiments.
References
[1] J.-S. Chang, L.-C. Chiang, C.-C. Chen, L.-T. Liu, K.-C.
Wang, and C.-C. Lin, “Atileukemic activity of Bidenspilosa
l. var. minor (Blume) sherﬀ and houttuynia cordata thunb,”
American Journal of Chinese Medicine, vol. 29, no. 2, pp. 303–
312, 2001.
[2] Y.-Y. Chen, C.-M. Chen, P.-Y. Chao, T.-J. Chang, and J.-F.
Liu, “Eﬀects of frying oil and Houttuynia cordata thunb on
xenobiotic-metabolizing enzyme system of rodents,” World
Journal of Gastroenterology, vol. 11, no. 3, pp. 389–392, 2005.
[3] Y.-Y. Chen, J.-F. Liu, C.-M. Chen, P.-Y. Chao, and T.-J. Chang,
“A study of the antioxidative and antimutagenic eﬀects of
Houttuynia cordata Thunb. Using an oxidized frying oil-fed
model,” Journal of Nutritional Science and Vitaminology, vol.
49, no. 5, pp. 327–333, 2003.
[4] L.-C. Chiang, J.-S. Chang, C.-C. Chen, L.-T. Ng, and C.-C.
Lin, “Anti-herpes simplex virus activity of Bidens pilosa and
Houttuynia cordata,” American Journal of Chinese Medicine,
vol. 31, no. 3, pp. 355–362, 2003.
[5] K. Hayashi, M. Kamiya, and T. Hayashi, “Virucidal eﬀects
of the steam distillate from Houttuynia cordata and its
components on HSV-1, inﬂuenza virus, and HIV,” Planta
Medica, vol. 61, no. 3, pp. 237–241, 1995.
[6] Y. Hou and X. Zhang, “Antiphlogistic action of Houttuynia
cordata injection in vitro and in mice,” Zhongguo Zhong Yao
Za Zhi, vol. 15, no. 4, pp. 221–222, 1990 (Chinese).
[7] S.-H. Hu and A.-F. Du, “Treatment of bovine mastitis with
houttuyninsodiumbisulphate,”JournalofVeterinaryMedicine
Series B, vol. 44, no. 6, pp. 365–370, 1997.Veterinary Medicine International 5
[8] K.-M. Lau, K.-M. Lee, C.-M. Koon, et al., “Immunomodula-
tory and anti-SARS activities of Houttuynia cordata,” Journal
of Ethnopharmacology, vol. 118, no. 1, pp. 79–85, 2008.
[9] G.-Z. Li, O.-H. Chai, M.-S. Lee, E.-H. Han, H.-T. Kim, and
C.-H. Song, “Inhibitory eﬀects of Houttuynia cordata water
extracts on anaphylactic reaction and mast cell activation,”
Biological and Pharmaceutical Bulletin, vol. 28, no. 10, pp.
1864–1868, 2005.
[10] H.-M. Lu, Y.-Z. Liang, and S. Chen, “Identiﬁcation and
quality assessment of Houttuynia cordata injection using
GC-MS ﬁngerprint: a standardization approach,” Journal of
Ethnopharmacology, vol. 105, no. 3, pp. 436–440, 2006.
[11] H.-M. Lu, Y.-Z. Liang, L.-Z. Yi, and X.-J. Wu, “Anti-
inﬂammatory eﬀect of Houttuynia cordata injection,” Journal
of Ethnopharmacology, vol. 104, no. 1–2, pp. 245–249, 2006.
[12] H. Lu, X. Wu, Y. Liang, and J. Zhang, “Variation in chemical
composition and antibacterial activities of essential oils from
two species of Houttuynia THUNB,” Chemical and Pharma-
ceutical Bulletin, vol. 54, no. 7, pp. 936–940, 2006.
[13] J. Meng, X.-P. Dong, Z.-H. Jiang, S.-Y. Leung, and Z.-Z. Zhao,
“Study on chemical constituents of ﬂavonoids in fresh herb of
Houttuynia cordata,” Zhongguo Zhongyao Zazhi, vol. 31, no.
16, pp. 1335–1337, 2006.
[14] J. Meng, X.-P. Dong, Y.-S. Zhou, Z.-H. Jiang, S.-Y. Leung, and
Z.-Z. Zhao, “Studies on chemical constituents of phenols in
fresh Houttuynia cordata,” Zhongguo Zhongyao Zazhi, vol. 32,
no. 10, pp. 929–931, 2007 (Chinese).
[15] D. Wang, Q. Yu, P. Eikstadt, D. Hammond, Y. Feng, and N.
Chen, “Studies on adjuvanticity of sodium houttuyfonate and
its mechanism,” International Immunopharmacology, vol. 2,
no. 10, pp. 1411–1418, 2002.
[16] C.-J. Xu, Y.-Z. Liang, and F.-T. Chau, “Identiﬁcation of essen-
tial components of Houttuynia cordata by gas chromatog-
raphy/mass spectrometry and the integrated chemometric
approach,” Talanta, vol. 68, no. 1, pp. 108–115, 2005.
[17] R. Xu, L.-M. Jiang, J.-M. He, and Y.-L. Liu, “The condensation
mechanism of sodium new houttuyfonate and determination
of the chemical structure of condensation products,” Yao Xue
Xue Bao, vol. 44, no. 6, pp. 609–614, 2009 (Chinese).
[18] X.-F. Yang, H. Yao, J.-B. Zhai, and H. Li, “Chemiluminescence
determination of sodium new houttuyfonate in pharmaceu-
tical preparations based on Tween 80-rhodamine B system,”
Journal of Fluorescence, vol. 17, no. 1, pp. 15–21, 2007.
[19] S.-Z. Cao, Experimental Technique in Veterinary Microbiology
and Immunology, Beijing Agricultural University Press, Bei-
jing, China, 1991.
[20] I.-S. Kim, J.-H. Kim, J.-S. Kim, C.-Y. Yun, D.-H. Kim, and J.-
S. Lee, “The inhibitory eﬀect of Houttuynia cordata extract
on stem cell factor-induced HMC-1 cell migration,” Journal
of Ethnopharmacology, vol. 112, no. 1, pp. 90–95, 2007.
[21] T.-V. Leshchinsky and K.-C. Klasing, “Proﬁle of chicken
cytokines induced by lipopolysaccharide is modulated by
dietary alpha-tocopheryl acetate,” Poultry Science, vol. 82, no.
8, pp. 1266–1273, 2003.
[22] I.-I. Bobyntsev, A.-A. Dolzhikov, and L.-A. Severyanova,
“Morphological changes in immune and endocrine organs
of mice injected with a gonadotropin-releasing hormone
analog,” Bulletin of Experimental Biology and Medicine, vol.
139, no. 1, pp. 101–104, 2005.
[23] G. Isitmangil, T. Isitmangil, K. Balkanli, K. Cerrahoglu, and
E. Kunter, “Detection of thoracotomy-induced alterations in
cell- and humoral-mediated immune response,” European
Journal of Cardio-thoracic Surgery, vol. 21, no. 3, pp. 497–501,
2002.
[24] M.-S. Khalifeh, M.-M. Amawi, E.-A. Abu-Basha, and I.-B.
Yonis,“Assessmentofhumoralandcellular-mediatedimmune
response in chickens treated with tilmicosin, ﬂorfenicol, or
enroﬂoxacin at the time of Newcastle disease vaccination,”
Poultry Science, vol. 88, no. 10, pp. 2118–2124, 2009.